U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06922994) titled 'Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)' on Jan. 20.

Brief Summary: The goal of this clinical trial is to learn if Atorvastatin 80 mg is effective to avoid functional right ventricular deterioration in patients affected by Arrhythmogenic Cardiomyopathy. It will also learn about the safety of Atorvastatin 80 mg in this type of patients. The main questions it aims to answer are:

1. Does Atorvastatin 80 mg prevent worstening of the right ventricular functioning?

2. Does Atorvastatin 80 mg prevent the worsening of electric, morphological and biomarkers deterioration?

3. What medical problems do pa...